However, emerging evidence has demonstrated that rationale should be followed to combine HDAC inhibitors with immunotherapy to obtain synergistic effect due to complexity of HDAC inhibitors on immune system and tumor microenvironment [47]. Here, HDAC9 is linked to neoplasm.